Discussion
DIMS
MYOPIA
Although the present study is not a formal randomised controlled trial, the results are novel in reporting the effects of DIMS spectacle lenses and atropine, in isolation and combined, in a European population. The findings indicate that 0.01% atropine and DIMS are individually effective in this population, and even more effective when combined.It has become commonplace in the literature on myopia control to use percentage reduction in progression as an index to describe treatment effect, but Brennan and colleagues cautioned that this can be misleading [The proportion of participants who showed, from baseline to 12 months, no increase in axial length was in the DIMS group 10%, in the atropine group 15%, and in the atropine+DIMS group 18%, compared with only 2% of the control group. Lam and colleagues reported that 14% of children wearing DIMS showed no axial elongation over 2 years [Recent studies indicate a dose effect of atropine and suggest that 0.05% may be the optimum dose for balancing efficacy with side effects [